Long-Term Consequences Of Intensive Care Patients Diagnosed With COVID-19 Infection After Hospital Discharge

Year 2022, , 503 - 507, 30.12.2022

Yücel Gültekin Zerrin Özçelik

https://doi.org/10.18663/tjcl.1170386

Abstract

Introduction: The Covid 19 pandemic has become a serious health problem that spreads rapidly in the world and in our country. The problems that may be encountered in the future in patients with Covid-19 infection are still unknown. This study aimed to evaluate long-term symptoms following Covid-19 infection.
Materials and Methods:This study evaluated post-discharge continued symptoms of patients hospitalized in the intensive care unit with the diagnosis of Covid-19.
Results: The most common symptom that persisted after Covid-19 infection was fatigue. It was determined that as the age of the patient increases, the incidence of symptoms after Covid-19 infection increases.
Conclusion: There are persistent symptoms after Covid-19 infection. Their identification is crucial for early diagnosis and treatment.

Keywords

COVID-19, intensive care, long-term

COVİD-19 Enfeksiyonu Tanısı Konan Yoğun Bakım Hastalarının Hastaneden Taburcu Sonrası Uzun Vadeli Sonuçları

Abstract

Giriş: Covid 19 salgını dünyada ve ülkemizde hızla yayılım gösteren ciddi bir sağlık sorunu haline gelmiştir. Covid-19 enfeksiyonu geçirmiş hastalarda ileri ki dönemlere ait karşılaşılacak sorunlar hala bilinmemektedir. Bu çalışmada covid-19 enfeksiyonu sonrası devam eden semptomları değerlendirilmesi amaçlanmıştır.
Materyal ve Method: Bu çalışmada covid-19 tanısı nedeni ile yoğun bakımda yatan hastaların taburculuk sonrası devam eden semptomları değerlendirilmiştir.
Bulgular: Covid-19 enfeksiyonu sonrası devam eden en sık semptomun halsizlik olduğu görüldü. Hasta yaşının artışı ile covid-19 enfeksiyonu sonrası semptomların görülme sıklığı artmaktadır.
Sonuç: Covid-19 enfeksiyonu sonrası devam eden semptomlar mevcuttur. Bunların tanınması erken tanı ve tedavi için önemlidir.

Keywords

COVİD-19, yoğun bakım, uzun dönem, COVID-19, intensive care, long-term

References

• 1. Perego E. Twitter 20 May 2020. https://twitter.com/elisaperego78/status/1263172084055838721
• 2. Edwards E. COVID-19 "long-haulers" report nearly 100 symptoms for more than 100 days. NBC News. Available at: https://www.nbcnews. com/health/health-news/covid-19-long-haulers-report-nearly-100-symptoms-more-100-n1235217. Accessed Feb 16, 2022
• 3. Yong E. COVID-19 can last for several months. The Atlantic. Available at: https://www.theatlantic.com/health/archive/2020/06/covid-19-coronavirus-longterm-symptoms-months/612679/. Accessed Feb 11, 2022
• 4. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372 doi:10.1136/bmj.n136
• 5. Carfì A, Bernabei R, Landi F. Persistent symptoms in patient safter acute COVID-19. JAMA 2020;324(6):603-5. doi: 10.1001/jama.2020.12603.
• 6. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985
• 7. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399-401. doi: 10.1136/thoraxjnl-2020-216086.
• 8. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021;30;2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617. Preprint
• 9. Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with covıd-19 in a multistate health care systems network - united states, march-june 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. doi: 10.15585/mmwr.mm6930e1.
• 10. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of Long-COVID. Nat Med. 2021;27(4):626-31. doi: 10.1038/s41591-021-01292-y.
• 11. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. doi: 10.1371/journal.pone.0240784
• 12. Fraser E.. Long term respiratory complications of covid-19. BMJ 2020;370:m300. doi: 10.1136/bmj.m3001
• 13. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55e8.doi: 10.1016j.ijid.2020.03.062
• 14. Lu Y, Li X, Geng D, Mei N, Wu P, Huang C, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3- monthfollow-upstudy. EClinicalMedicine. 2020; 25: 100484. doi: 10.1016/j.eclinm.2020.100484.
• 15. Chandrashekara S, Jaladhar P, Paramshetti S, Ramachandran V, Nizar SF, Kori D. Post COVID inflammation syndrome: different manifestations caused by the virus. J Assoc Phys India 2020;68(12):33e4.
• 16. Dasgupta A, Kalhan A, Kalra S. Long term complications and rehabilitation of COVID-19 patients. J Pakistan MedAssoc 2020;70: (5):131-5. doi:10.5455/JPMA.32.
• 17. Casas CG, Catala A, Hernandez GC, Jimenez PR, Fernandez-Nieto D, Lario ARV, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nation wide consensus study in Spain with 375 cases. Br J Dermatol 2020;183(1):71-7. doi: 10.1111/bjd.19163.